Search “Anthropic”

Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

On October 26, 2026, Anthropic publicly submitted a Form S-1 registration statement, planning to list on Nasdaq under the ticker ANT. The prospectus disclosed revenue of $16.3 billion for the first half of 2026 and operating profit of $974 million in the second quarter, and listed an NVIDIA compute commitment of up to $120.5 billion. Subsequently, in its October 28 IPO filing, Anthropic acknowledged that its life sciences business lacks physical laboratory experience and flagged related drug development risks; Goldman Sachs serves as lead underwriter for the prospectus. TechCrunch reported that after the IPO, public shareholders will have almost no say over board appointments. On October 29, the prospectus disclosed four previously undisclosed Agent safety incidents. On October 30, Reuters reported that its IPO fundraising cap could reach $100 billion; Steve Eisman accused the prospectus of deliberately omitting third-quarter data. On November 2, Anthropic filed an amended S-1/A, disclosing approximately $895.4 billion in compute procurement and leasing commitments, and reporting third-quarter revenue of $16.956 billion, up 1,127% year over year, with an operating loss of $567 million for the quarter.

Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

On October 26, 2026, Anthropic publicly submitted a Form S-1 registration statement, planning to list on Nasdaq under the ticker ANT. The prospectus disclosed revenue of $16.3 billion for the first half of 2026 and operating profit of $974 million in the second quarter, and listed an NVIDIA compute commitment of up to $120.5 billion. Subsequently, in its October 28 IPO filing, Anthropic acknowledged that its life sciences business lacks physical laboratory experience and flagged related drug development risks; Goldman Sachs serves as lead underwriter for the prospectus. TechCrunch reported that after the IPO, public shareholders will have almost no say over board appointments. On October 29, the prospectus disclosed four previously undisclosed Agent safety incidents. On October 30, Reuters reported that its IPO fundraising cap could reach $100 billion; Steve Eisman accused the prospectus of deliberately omitting third-quarter data. On November 2, Anthropic filed an amended S-1/A, disclosing approximately $895.4 billion in compute procurement and leasing commitments, and reporting third-quarter revenue of $16.956 billion, up 1,127% year over year, with an operating loss of $567 million for the quarter.

View story:Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

Anthropic's third-quarter revenue approaches $17 billion

On October 26, 2026, Anthropic publicly submitted a Form S-1 registration statement, planning to list on Nasdaq under the ticker ANT. The prospectus disclosed revenue of $16.3 billion for the first half of 2026 and operating profit of $974 million in the second quarter, and listed an NVIDIA compute commitment of up to $120.5 billion. Subsequently, in its October 28 IPO filing, Anthropic acknowledged that its life sciences business lacks physical laboratory experience and flagged related drug development risks; Goldman Sachs serves as lead underwriter for the prospectus. TechCrunch reported that after the IPO, public shareholders will have almost no say over board appointments. On October 29, the prospectus disclosed four previously undisclosed Agent safety incidents. On October 30, Reuters reported that its IPO fundraising cap could reach $100 billion; Steve Eisman accused the prospectus of deliberately omitting third-quarter data. On November 2, Anthropic filed an amended S-1/A, disclosing approximately $895.4 billion in compute procurement and leasing commitments, and reporting third-quarter revenue of $16.956 billion, up 1,127% year over year, with an operating loss of $567 million for the quarter.

View story:Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

Bloomberg discloses that Anthropic accounted for 34.5% of SpaceX's third-quarter revenue

According to Bloomberg, Anthropic has become SpaceX's largest single customer, a position previously held by the U.S. federal government. Documents filed by SpaceX last week show that about 34.5% of revenue in the previous quarter came from a single customer, which mainly purchases computing power services from its artificial intelligence division, and people familiar with the matter confirmed that the customer is Anthropic. Anthropic mainly leases computing resources from SpaceX's data center in Memphis, Tennessee; the contract is valid until 2029, with a potential spending cap of $120.5 billion, requiring monthly payments of about $3.1 billion starting in December of this year, and the contract may be canceled after early 2027 with 90 days' written notice. Cailianshe reported on the same day, also citing people familiar with the matter, that about 34.5% of SpaceX's revenue for the quarter came from a computing power payer labeled "Customer B."

Reuters reports Anthropic plans IPO to raise up to $100 billion

On October 26, 2026, Anthropic publicly submitted a Form S-1 registration statement, planning to list on Nasdaq under the ticker ANT. The prospectus disclosed revenue of $16.3 billion for the first half of 2026 and operating profit of $974 million in the second quarter, and listed an NVIDIA compute commitment of up to $120.5 billion. Subsequently, in its October 28 IPO filing, Anthropic acknowledged that its life sciences business lacks physical laboratory experience and flagged related drug development risks; Goldman Sachs serves as lead underwriter for the prospectus. TechCrunch reported that after the IPO, public shareholders will have almost no say over board appointments. On October 29, the prospectus disclosed four previously undisclosed Agent safety incidents. On October 30, Reuters reported that its IPO fundraising cap could reach $100 billion; Steve Eisman accused the prospectus of deliberately omitting third-quarter data. On November 2, Anthropic filed an amended S-1/A, disclosing approximately $895.4 billion in compute procurement and leasing commitments, and reporting third-quarter revenue of $16.956 billion, up 1,127% year over year, with an operating loss of $567 million for the quarter.

View story:Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

Eisman accuses Anthropic's prospectus of deliberately withholding third-quarter data

On October 26, 2026, Anthropic publicly submitted a Form S-1 registration statement, planning to list on Nasdaq under the ticker ANT. The prospectus disclosed revenue of $16.3 billion for the first half of 2026 and operating profit of $974 million in the second quarter, and listed an NVIDIA compute commitment of up to $120.5 billion. Subsequently, in its October 28 IPO filing, Anthropic acknowledged that its life sciences business lacks physical laboratory experience and flagged related drug development risks; Goldman Sachs serves as lead underwriter for the prospectus. TechCrunch reported that after the IPO, public shareholders will have almost no say over board appointments. On October 29, the prospectus disclosed four previously undisclosed Agent safety incidents. On October 30, Reuters reported that its IPO fundraising cap could reach $100 billion; Steve Eisman accused the prospectus of deliberately omitting third-quarter data. On November 2, Anthropic filed an amended S-1/A, disclosing approximately $895.4 billion in compute procurement and leasing commitments, and reporting third-quarter revenue of $16.956 billion, up 1,127% year over year, with an operating loss of $567 million for the quarter.

View story:Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

Bloomberg discloses that Anthropic accounted for 34.5% of SpaceX's third-quarter revenue

According to Bloomberg, Anthropic has become SpaceX's largest single customer, a position previously held by the U.S. federal government. Documents filed by SpaceX last week show that about 34.5% of revenue in the previous quarter came from a single customer, which mainly purchases computing power services from its artificial intelligence division, and people familiar with the matter confirmed that the customer is Anthropic. Anthropic mainly leases computing resources from SpaceX's data center in Memphis, Tennessee; the contract is valid until 2029, with a potential spending cap of $120.5 billion, requiring monthly payments of about $3.1 billion starting in December of this year, and the contract may be canceled after early 2027 with 90 days' written notice. Cailianshe reported on the same day, also citing people familiar with the matter, that about 34.5% of SpaceX's revenue for the quarter came from a computing power payer labeled "Customer B."

View story:Bloomberg discloses that Anthropic accounted for 34.5% of SpaceX's third-quarter revenue

Anthropic reports that about 250 customers spent over $10 million on Claude within 12 months

Anthropic reports that about 250 customers spent more than $10 million on Claude over a 12-month period. The same report also mentions that every Fortune 10 company pays Anthropic more than $100,000 per year, and more than 50% of Fortune 500 companies and more than 30% of Global 2000 companies also reach this level. The report states that in 2025, customers paying more than $100,000 per year contributed 76% of Anthropic's revenue, compared with 90% in 2023. This information is currently posted by Rohan Paul, has not been cross-verified by other sources, and no subsequent developments have been seen.

Anthropic reports that about 250 customers spent over $10 million on Claude within 12 months

Anthropic reports that about 250 customers spent more than $10 million on Claude over a 12-month period. The same report also mentions that every Fortune 10 company pays Anthropic more than $100,000 per year, and more than 50% of Fortune 500 companies and more than 30% of Global 2000 companies also reach this level. The report states that in 2025, customers paying more than $100,000 per year contributed 76% of Anthropic's revenue, compared with 90% in 2023. This information is currently posted by Rohan Paul, has not been cross-verified by other sources, and no subsequent developments have been seen.

View story:Anthropic reports that about 250 customers spent over $10 million on Claude within 12 months

Rohan Paul says Anthropic S-1 shows R&D consumes most of the compute

On October 26, 2026, Anthropic publicly submitted a Form S-1 registration statement, planning to list on Nasdaq under the ticker ANT. The prospectus disclosed revenue of $16.3 billion for the first half of 2026 and operating profit of $974 million in the second quarter, and listed an NVIDIA compute commitment of up to $120.5 billion. Subsequently, in its October 28 IPO filing, Anthropic acknowledged that its life sciences business lacks physical laboratory experience and flagged related drug development risks; Goldman Sachs serves as lead underwriter for the prospectus. TechCrunch reported that after the IPO, public shareholders will have almost no say over board appointments. On October 29, the prospectus disclosed four previously undisclosed Agent safety incidents. On October 30, Reuters reported that its IPO fundraising cap could reach $100 billion; Steve Eisman accused the prospectus of deliberately omitting third-quarter data. On November 2, Anthropic filed an amended S-1/A, disclosing approximately $895.4 billion in compute procurement and leasing commitments, and reporting third-quarter revenue of $16.956 billion, up 1,127% year over year, with an operating loss of $567 million for the quarter.

View story:Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

TechCrunch reports that after Anthropic's IPO, public shareholders have almost no say over the board

On October 26, 2026, Anthropic publicly submitted a Form S-1 registration statement, planning to list on Nasdaq under the ticker ANT. The prospectus disclosed revenue of $16.3 billion for the first half of 2026 and operating profit of $974 million in the second quarter, and listed an NVIDIA compute commitment of up to $120.5 billion. Subsequently, in its October 28 IPO filing, Anthropic acknowledged that its life sciences business lacks physical laboratory experience and flagged related drug development risks; Goldman Sachs serves as lead underwriter for the prospectus. TechCrunch reported that after the IPO, public shareholders will have almost no say over board appointments. On October 29, the prospectus disclosed four previously undisclosed Agent safety incidents. On October 30, Reuters reported that its IPO fundraising cap could reach $100 billion; Steve Eisman accused the prospectus of deliberately omitting third-quarter data. On November 2, Anthropic filed an amended S-1/A, disclosing approximately $895.4 billion in compute procurement and leasing commitments, and reporting third-quarter revenue of $16.956 billion, up 1,127% year over year, with an operating loss of $567 million for the quarter.

View story:Anthropic publicly submits S-1 registration statement for proposed IPO on Nasdaq

Anthropic partners with six institutions to advance drug discovery

Anthropic's life sciences team has established research collaborations with six institutions—Generate Biomedicines, Divergence Labs, BigHat Biosciences, Enveda, The Column Group, and Bristol Myers Squibb—to jointly develop new drugs, while also acquiring Mithril Medicine, a biotechnology company independently operated by Cody Tranbarger, to directly conduct drug research and development. Anthropic says Claude has already delivered quantifiable improvements in molecular design, manufacturing document review, regulatory filings, and clinical trial planning; for example, Enveda used Claude to review 1,061 pages of documents, identifying all 11 issues found by humans and flagging 7 additional ones, cutting manual review time from more than 25 hours to less than 3 hours. Anthropic says it plans to significantly expand this work, and if candidate drugs perform well, it expects to be ready to launch human clinical trials as early as the end of 2028.

GSA and Anthropic expand OneGov agreement, Claude procurement discount 40%

On October 27, 2026, the U.S. General Services Administration (GSA) and Anthropic announced the expansion of the OneGov agreement, under which government buyers receive a 40% usage-based discount on Claude Enterprise, Claude for Government, and the Claude API, with eligibility extended from the federal government to state, local, tribal, and territorial governments. The agreement sets no minimum purchase volume; agencies pay only for actual usage and can order through direct sales, resellers, and major cloud platforms. Anthropic says about 500 U.S. federal, state, and local government agencies use Claude, and weekly active users of Claude for Government have grown roughly eightfold since February 2026. Other reports say the previous $1-per-person federal Claude offer will expire on October 31, with the 40% discount replacing that program and set to extend in the coming months to orders procured through cloud providers.

Reservoir sues Suno and Anthropic over unauthorized use of songs to train AI

Reservoir has filed lawsuits against Suno and Anthropic, alleging that both companies used songs and lyrics to train AI systems without authorization, with the two cases seeking a combined 338 million US dollars in damages. According to CNET, Reservoir claims that Suno admitted during the trial of the 2024 record label lawsuit that it had copied nearly all music files of passable quality on the open internet; Anthropic, meanwhile, is accused of deleting attribution information. Anthropic said it disagrees with the allegations and will actively defend itself in court. The case is currently at the filing stage, with no subsequent developments yet.

Reservoir sues Suno and Anthropic over unauthorized use of songs to train AI

Reservoir has filed lawsuits against Suno and Anthropic, alleging that both companies used songs and lyrics to train AI systems without authorization, with the two cases seeking a combined 338 million US dollars in damages. According to CNET, Reservoir claims that Suno admitted during the trial of the 2024 record label lawsuit that it had copied nearly all music files of passable quality on the open internet; Anthropic, meanwhile, is accused of deleting attribution information. Anthropic said it disagrees with the allegations and will actively defend itself in court. The case is currently at the filing stage, with no subsequent developments yet.

View story:Reservoir sues Suno and Anthropic over unauthorized use of songs to train AI

Anthropic partners with six institutions to advance drug discovery

Anthropic's life sciences team has established research collaborations with six institutions—Generate Biomedicines, Divergence Labs, BigHat Biosciences, Enveda, The Column Group, and Bristol Myers Squibb—to jointly develop new drugs, while also acquiring Mithril Medicine, a biotechnology company independently operated by Cody Tranbarger, to directly conduct drug research and development. Anthropic says Claude has already delivered quantifiable improvements in molecular design, manufacturing document review, regulatory filings, and clinical trial planning; for example, Enveda used Claude to review 1,061 pages of documents, identifying all 11 issues found by humans and flagging 7 additional ones, cutting manual review time from more than 25 hours to less than 3 hours. Anthropic says it plans to significantly expand this work, and if candidate drugs perform well, it expects to be ready to launch human clinical trials as early as the end of 2028.

View story:Anthropic partners with six institutions to advance drug discovery

GSA and Anthropic expand OneGov agreement, Claude procurement discount 40%

On October 27, 2026, the U.S. General Services Administration (GSA) and Anthropic announced the expansion of the OneGov agreement, under which government buyers receive a 40% usage-based discount on Claude Enterprise, Claude for Government, and the Claude API, with eligibility extended from the federal government to state, local, tribal, and territorial governments. The agreement sets no minimum purchase volume; agencies pay only for actual usage and can order through direct sales, resellers, and major cloud platforms. Anthropic says about 500 U.S. federal, state, and local government agencies use Claude, and weekly active users of Claude for Government have grown roughly eightfold since February 2026. Other reports say the previous $1-per-person federal Claude offer will expire on October 31, with the 40% discount replacing that program and set to extend in the coming months to orders procured through cloud providers.

View story:GSA and Anthropic expand OneGov agreement, Claude procurement discount 40%

Cathedral claims to have used an AI agent to breach Anthropic's internal systems

On October 26, 2026, Hugging Face CEO Clément Delangue commented on a report, saying that if one believes concentrating AI in a closed environment makes it safe, that judgment needs updating. The report he cited said that a group of former DOGE cybersecurity researchers used AI agents to penetrate Anthropic's systems in less than 12 hours, including the Slack channels where the most sensitive models were discussed. The next day, the security startup Cathedral was reported to have used AI agents in a security test authorized by Anthropic to enter its sales, HR, and IT systems through third-party enterprise software vulnerabilities in less than 12 hours, accessing meeting transcripts, compensation and hiring details, and internal Slack messages. Anthropic confirmed the intrusion was real but stressed that messages customers sent to Claude, core code, and model weights were not leaked, and said its monitoring system had detected anomalies and cut off access before the report was submitted.

View story:Clément Delangue says developing AI in a closed manner is not safe

Replit CEO says it is no longer working with Anthropic

Replit CEO Amjad Masad confirmed during an onstage interview at TechCrunch Disrupt 2026 that the company is no longer working with Anthropic, citing cost, partnership, and performance reasons, and said GPT is now a better fit for Replit's workloads. He noted that Replit had been one of Anthropic's top five customers, and citing internal VBench and public benchmarks, said OpenAI's Sol and Astra models perform better at building vibe-coded apps from scratch. A subsequent TechCrunch AI report said Masad clarified that users can still access Anthropic models on the platform, but OpenAI's ChatGPT has become the default model. Masad also said the share of revenue from enterprise contracts rose from about 2% in 2025 to about 15% in 2026, with more than 50% of revenue now coming from B2B.

Authentic Brands Group sues Anthropic for copyright infringement of 274 songs

On October 25, 2026, Authentic Brands Group and several publishers that jointly hold the Elvis Presley catalog filed a federal lawsuit, ABE EPE LLC v. Anthropic, alleging that Claude was trained on 274 songs and seeking approximately $41 million in damages at the statutory maximum of $150,000 per song for willful infringement. The lawsuit targets both training and output, claiming that Claude reproduced nearly the entire online catalog even after Anthropic added safeguards in response to earlier publisher litigation, and citing Claude's own account that its rewrites preserved the original songs' structure and hooks. Anthropic had not responded when the lawsuit was first reported, and the claims have not been tested in court; in 2025 a federal judge ruled that training Claude on lawfully purchased books was fair use, but portions of output resembling lyrics fall outside the scope of that ruling.